“…Since their development of an enantioselective allylic alkylation, the Stoltz group has increased the scope of this transformation substantially to include, 1,3-dioxan-5-one- ( 9 ), 21 β-thiocyclohexenone-( 10 ), 22,23 3-ketal- ( 11 ), 24 β-alkoxy-cycloheptenone- ( 12 ), 25,26 5-alkyl- and 5-alkoxy- ( 13 ), β-aminocyclohexenone- ( 14 ), 1-alkoxypiperidine-2,6-dione- ( 15 ), dihydropyridin-4(1 H )-one- ( 16 ), 27 cyclobutanone- ( 17 ), 28 valerolactam and 2-piperazinone- ( 18 ), 29 2-aminomethylcyclohexanone- ( 19 ), 30 4-oxazolidinone- ( 20 ), morpholin-3-one- ( 21 ), 1,2-oxazepan-3-one- ( 22 ), 31 and cyclopentanone-based ( 23 ) 32 allyl β-ketoesters (Figure 2). Notably, the use of oxygen- and nitrogen-based heterocycles allows for the facile synthesis of quaternary stereocenter-bearing polyketide and pharmaceutical-type fragments in a straightforward manner.…”